{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:41:56Z","timestamp":1794062516250,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005239","name":"Indian Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.02.065","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T20:24:05Z","timestamp":1713299045000},"page":"125748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S3","title":["Overview of U.S. COVID-19 vaccine safety surveillance systems"],"prefix":"10.1016","volume":"42","author":[{"given":"Julianne","family":"Gee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Buddy Creech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Forshee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Hause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kracalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Loran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Schupbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.065_b0005","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations_vacc-people-booster-percent-total on June 1, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0010","unstructured":"Hlavka J, Rose, A. 2023;Pages. Accessed at Fortune Media IP Limited at https:\/\/fortune.com\/well\/2023\/05\/16\/how-much-did-covid-19-pandemic-coronavirus-cost-economy-14-trillion\/ on June 1, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.econmod.2022.106147","article-title":"Macroeconomic consequences of the COVID-19 pandemic","volume":"120","author":"Walmsley","year":"2023","journal-title":"Econ Model"},{"key":"10.1016\/j.vaccine.2024.02.065_b0020","unstructured":"Fitzpatrick M, Moghadas, SM, Pandey, A, Galvani, AP 2022;Pages. Accessed at The Commonwealth Fund at https:\/\/www.commonwealthfund.org\/blog\/2022\/two-years-covid-vaccines-prevented-millions-deaths-hospitalizations on June 1, 2023 2023."},{"issue":"7876","key":"10.1016\/j.vaccine.2024.02.065_b0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.02.065_b0030","unstructured":"Food and Drug Administration;Pages. Accessed at Food and Drug Administration at https:\/\/www.fda.gov\/media\/151733\/download on June 3, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0035","unstructured":"Brighton Collaboration 2023;Pages. Accessed at Brighton Collaboration at https:\/\/brightoncollaboration.us\/category\/pubs-tools\/case-definitions\/ on June 9, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0040","unstructured":"Council for International Organizations of Medical Sciences Workgroup VIII 2010;Pages. Accessed at Council for International Organizations of Medical Sciences at https:\/\/cioms.ch\/publications\/product\/practical-aspects-of-signal-detection-in-pharmacovigilance-report-of-cioms-working-group-viii\/ on July 27, 2023 2023."},{"issue":"36","key":"10.1016\/j.vaccine.2024.02.065_b0045","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.065_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2146\/ajhp110026","article-title":"Monitoring adverse drug reactions across a nationwide health care system using information technology","volume":"69","author":"Emmendorfer","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.065_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/07474946.2011.539924","article-title":"Platt R A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance","volume":"30","author":"Kulldorff","year":"2011","journal-title":"Seq Anal"},{"key":"10.1016\/j.vaccine.2024.02.065_b0060","unstructured":"Centers for Disease Control and Prevention 2022;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/vsd\/index.html on June 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0065","unstructured":"Food and Drug Administration 2023;Pages. Accessed at Food and Drug Administration at https:\/\/bestinitiative.org\/ on June 9, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0070","unstructured":"Food and Drug Administration 2021;Pages. Accessed at Food and Drug Administration at https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/covid-19-vaccine-safety-surveillance#CMS on July 27, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0075","unstructured":"Lou J HK SC, Huang N, Pandey L, Thakkar B, Donahue M, Cunningham FE. Incidence rates and clinical characteristics of patients with confirmed myocarditis or pericarditis following COVID-19 mRNA vaccination: experience of the Veterans Health Administration through October 9, 2022. Open Forum Infectious Diseases. In Press."},{"key":"10.1016\/j.vaccine.2024.02.065_b0080","doi-asserted-by":"crossref","unstructured":"DeFraites RF. The Armed Forces Health Surveillance Center: enhancing the Military Health System's public health capabilities. BMC Public Health. 2011;11 Suppl 2(Suppl 2):S1.","DOI":"10.1186\/1471-2458-11-S2-S1"},{"key":"10.1016\/j.vaccine.2024.02.065_b0085","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/cisa\/index.html on June 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0090","unstructured":"U.S. Government Accountability Office 2007;Pages. Accessed at U.S. Government Accountability Office at https:\/\/www.gao.gov\/products\/gao-07-787r on September 19, 2023 2023."},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.065_b0095","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2022.12.031","article-title":"The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response","volume":"41","author":"Myers","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.065_b0100","unstructured":"Indian Health Service 2023;Pages. Accessed at Indian Health Service at https:\/\/www.ihs.gov\/nptc\/ on July 27, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0105","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/v-safe\/covid-preg-reg.html on June 9, 2023 2023."},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.065_b0110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2352-4642(22)00244-9","article-title":"Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study","volume":"6","author":"Kracalik","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2024.02.065_b0115","unstructured":"Food and Drug Administration 2023;Pages. Accessed at Food and Drug Administration at https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=312.32 on July 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0120","unstructured":"Centers for Disease Control and Prevention; Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/covid-19\/vaccination-provider-support.html#provider-agreement on May 31, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0125","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/emergencypreparedness\/index.html#anchor_1607961664745 on July 27, 2023 2023."},{"issue":"17","key":"10.1016\/j.vaccine.2024.02.065_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.065_b0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/CRIAI:24:3:263","article-title":"Adverse reactions to vaccines","volume":"24","author":"Martin","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.vaccine.2024.02.065_b0140","doi-asserted-by":"crossref","unstructured":"McNeil MM, Cano M, E RM, Petersen BW, Engler RJ, Bryant-Genevier MG. Ischemic cardiac events and other adverse events following ACAM2000(\u00ae) smallpox vaccine in the Vaccine Adverse Event Reporting System. Vaccine. 2014;32(37):4758-65.","DOI":"10.1016\/j.vaccine.2014.06.034"},{"issue":"37","key":"10.1016\/j.vaccine.2024.02.065_b0145","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2016.07.019","article-title":"Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009\u20132010 season in the active component U.S. military and civilians aged 17\u201344years reported to the Vaccine Adverse Event Reporting System","volume":"34","author":"Bardenheier","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.065_b0150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military","volume":"6","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.vaccine.2024.02.065_b0155","unstructured":"Loran D, Reyes A, Angelo S, Carbungco D, Ryan M. COVID-19 Vaccination Errors: Challenges and Opportunities for Improving Support of Immunization Clinics. Immunization Coalition Summit. Riverside, CA; 2023."},{"issue":"42","key":"10.1016\/j.vaccine.2024.02.065_b0160","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.065_b0165","doi-asserted-by":"crossref","unstructured":"Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 Supl 2):S89-95.","DOI":"10.1097\/MLR.0b013e3180616c0a"},{"issue":"14","key":"10.1016\/j.vaccine.2024.02.065_b0170","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.065_b0175","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.7326\/M22-2274","article-title":"Incidence of myocarditis\/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the United States","volume":"175","author":"Goddard","year":"2022","journal-title":"Ann Intern Med"},{"issue":"35","key":"10.1016\/j.vaccine.2024.02.065_b0180","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/j.vaccine.2022.07.007","article-title":"Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination","volume":"40","author":"Goddard","year":"2022","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.065_b0185","doi-asserted-by":"crossref","first-page":"e228879","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2024.02.065_b0190","unstructured":"Klein N 2023;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-09-12\/07-COVID-Klein-508.pdf on September 19, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0195","unstructured":"Klein N, Shimabukuro, T 2023;Pages. Accessed at Food and Drug Administration at https:\/\/www.fda.gov\/media\/164811\/download on July 27, 2023 2023."},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.065_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2205276","article-title":"Evaluation of acute adverse events after Covid-19 vaccination during pregnancy","volume":"387","author":"DeSilva","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.065_b0205","first-page":"125","article-title":"Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination","volume":"142","author":"DeSilva","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"45","key":"10.1016\/j.vaccine.2024.02.065_b0210","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1016\/j.vaccine.2022.09.060","article-title":"Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years","volume":"40","author":"Lloyd","year":"2022","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.065_b0215","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.vaccine.2022.11.069","article-title":"Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older","volume":"41","author":"Wong","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.065_b0220","unstructured":"Azadeh SLP, Wong HL, Clarke TC, Chillarige Y, Do R, Hu M, et al.; 2023. Accessed at medRxiv at https:\/\/www.medrxiv.org\/content\/10.1101\/2023.01.19.23284803v1 on June 9, 2023 2023."},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.065_b0225","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1017\/dmp.2020.478","article-title":"Myopericarditis associated with smallpox vaccination among US Army personnel - fort hood, Texas, 2018","volume":"16","author":"Mandra","year":"2022","journal-title":"Disaster Med Public Health Prep"},{"issue":"17","key":"10.1016\/j.vaccine.2024.02.065_b0230","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1016\/j.vaccine.2006.12.044","article-title":"A comparative assessment of immunization records in the defense medical surveillance system and the vaccine adverse event reporting system","volume":"25","author":"McNeil","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.065_b0235","unstructured":"Lang MA, Stahlman S, Wells NY, Fedgo AA, Patel DM, Chauhan A, et al. Disparities in COVID-19 vaccine initiation and completion among active component service members and health care personnel, 11 December 2020-12 March 2021. Msmr. 2021;28(4):2-9."},{"key":"10.1016\/j.vaccine.2024.02.065_b0240","doi-asserted-by":"crossref","unstructured":"Winkler EL, Stahlman SL, Wells NY, Chauhan AV, Hiban KM, Costello AA, et al. COVID-19 Booster Vaccination in the U.S. Military, August 2021-January 2022. Am J Prev Med. 2023;64(2):270-4.","DOI":"10.1016\/j.amepre.2022.07.017"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.065_b0245","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1097\/INF.0000000000003801","article-title":"Multiple MIS-C readmissions and giant coronary aneurysm after COVID-19 illness and vaccination: A case report","volume":"42","author":"Haq","year":"2023","journal-title":"Pediatr Infect Dis J"},{"issue":"27","key":"10.1016\/j.vaccine.2024.02.065_b0250","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.02.065_b0255","unstructured":"Centers for Disease Control and Prevention 2021;Pages. Accessed at CDC Health Alert Network at https:\/\/emergency.cdc.gov\/han\/2021\/han00442.asp on June 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0260","unstructured":"Centers for Disease Control and Prevention; Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/myocarditis.html on May 30, 2023 2023."},{"issue":"21","key":"10.1016\/j.vaccine.2024.02.065_b0265","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2024.02.065_b0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First Month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"39","key":"10.1016\/j.vaccine.2024.02.065_b0275","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine - United States, August 12-September 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"30","key":"10.1016\/j.vaccine.2024.02.065_b0280","doi-asserted-by":"crossref","first-page":"971","DOI":"10.15585\/mmwr.mm7130a4","article-title":"Safety monitoring of COVID-19 mRNA vaccine second booster doses among adults aged \u226550 years - United States, March 29, 2022-July 10, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"10.1016\/j.vaccine.2024.02.065_b0285","doi-asserted-by":"crossref","first-page":"899","DOI":"10.15585\/mmwr.mm7128a3","article-title":"Safety monitoring of COVID-19 mRNA vaccine first booster doses among persons aged \u226512 years with presumed immunocompromise status - United States, January 12, 2022-March 28, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.065_b0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.15585\/mmwr.mm7109e2","article-title":"Safety monitoring of COVID-19 vaccine booster doses among persons aged 12\u201317 Years - United States, December 9, 2021-February 20, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.vaccine.2024.02.065_b0295","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 vaccine safety in children aged 5\u201311 years - United States, November 3-December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.vaccine.2024.02.065_b0300","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.15585\/mmwr.mm7133a3","article-title":"Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5\u201311 Years - United States, May 17-July 31, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"10.1016\/j.vaccine.2024.02.065_b0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","article-title":"COVID-19 vaccine safety in adolescents aged 12\u201317 years - United States, December 14, 2020-July 16, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"10.1016\/j.vaccine.2024.02.065_b0310","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.15585\/mmwr.mm7144a3","article-title":"Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among persons aged \u226512 years - United States, August 31-October 23, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"35","key":"10.1016\/j.vaccine.2024.02.065_b0315","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7135a3","article-title":"COVID-19 mRNA vaccine safety among children aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.065_b0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15585\/mmwr.mm7202a5","article-title":"Safety monitoring of Bivalent COVID-19 mRNA vaccine booster doses among children aged 5\u201311 years - United States, October 12-January 1, 2023","volume":"72","author":"Hause","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.065_b0325","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.vaccine.2023.11.061","article-title":"CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description","volume":"42","author":"Madni","year":"2024","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2024.02.065_b0330","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.vaccine.2024.02.065_b0335","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2113891","article-title":"Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion","volume":"385","author":"Zauche","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.02.065_b0340","unstructured":"American College of Obstetrics and Gynecology; Society for Maternal Fetal Medicine 2021;Pages. Accessed at American College of Obstetrics and Gynecology at https:\/\/www.acog.org\/news\/news-releases\/2021\/07\/acog-smfm-recommend-covid-19-vaccination-for-pregnant-individuals on May 25, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0345","unstructured":"Centers for Disease Control and Prevention 2021;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/media\/releases\/2021\/s0811-vaccine-safe-pregnant.html on May 25, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0350","unstructured":"Ellington SR, Kharbanda, E.O., Olson, C.K., Fleming-Dutra, K.E. COVID-19 in pregnant people and infants ages 0-5 months; COVID-19 vaccine safety in pregnancy; Effectiveness of maternal COVID-19 vaccination in pregnant and infants. Advisory Committee on Immunization Practices. Atlanta, GA: Centers for Disease Control and Prevention; 2022."},{"key":"10.1016\/j.vaccine.2024.02.065_b0355","unstructured":"Olson CK. Updates from the v-safe COVID-19 vaccine pregnancy registry. Advisory Committee on Immunization Practices Atlanta, GA: Centers for Disease Controla and Prevention; 2021."},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.065_b0360","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamainternmed.2020.9241","article-title":"Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19","volume":"181","author":"Jering","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.02.065_b0365","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/cid\/ciab344","article-title":"Adverse pregnancy outcomes, maternal complications, and severe illness among US delivery hospitalizations with and without a coronavirus disease 2019 (COVID-19) diagnosis","volume":"73","author":"Ko","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.065_b0370","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/1471-0528.16403","article-title":"Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study","volume":"127","author":"Prabhu","year":"2020","journal-title":"BJOG"},{"issue":"44","key":"10.1016\/j.vaccine.2024.02.065_b0375","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.02.065_b0380","unstructured":"Food and Drug Administration 2020;Pages. Accessed at Food and Drug Administration at https:\/\/web.archive.org\/web\/20201231184246\/https:\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines on May 23, 2023 2023."},{"issue":"10287","key":"10.1016\/j.vaccine.2024.02.065_b0385","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(21)01018-7","article-title":"COVID-19 vaccine impact in Israel and a way out of the pandemic","volume":"397","author":"Leshem","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.065_b0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13584-021-00440-6","article-title":"Israel's rapid rollout of vaccinations for COVID-19","volume":"10","author":"Rosen","year":"2021","journal-title":"Isr J Health Policy Res"},{"issue":"23","key":"10.1016\/j.vaccine.2024.02.065_b0395","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2024.02.065_b0400","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after Covid-19 vaccination in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"issue":"S3","key":"10.1016\/j.vaccine.2024.02.065_b0405","article-title":"COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic","volume":"42","author":"Markowitz","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.065_b0410","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US From December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"issue":"10342","key":"10.1016\/j.vaccine.2024.02.065_b0415","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.065_b0420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis With COVID-19 mRNA Vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2024.02.065_b0425","doi-asserted-by":"crossref","unstructured":"Jain SS, Anderson SA, Steele J, et al. Outcomes in COVID-19 mRNA Vaccine-Associated Myocarditis in the Young in the United States: Results from The Myocarditis After COVID Vaccination (MACiV) Multicenter Longitudinal Study. Available at SSRN: https:\/\/ssrn.com\/abstract=4681858 or https:\/\/dx.doi.org\/10.2139\/ssrn.4681858.","DOI":"10.2139\/ssrn.4681858"},{"key":"10.1016\/j.vaccine.2024.02.065_b0430","unstructured":"Centers for Disease Control and Prevention 2022;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/acip\/work-groups-vast\/index.html on July 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0435","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/acip\/index.html on June 1, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0440","unstructured":"Food and Drug Administration 2023;Pages. Accessed at Food and Drug Administration at https:\/\/www.fda.gov\/advisory-committees\/blood-vaccines-and-other-biologics\/vaccines-and-related-biological-products-advisory-committee on June 1, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0445","unstructured":"World Health Organization 2023;Pages. Accessed at World Health Organization at https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety on June 4, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0450","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html#contraindications on September 15, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0455","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/index.html on July 2, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0460","unstructured":"Centers for Disease Control and Prevention;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/safety-of-vaccines.html on June 1, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0465","unstructured":"European Medicines Agency. Accessed at European Medicines Agency at https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-and-development\/pharmacovigilance-research-and-development\/eudravigilance on February 11, 2024."},{"key":"10.1016\/j.vaccine.2024.02.065_b0470","unstructured":"European Medicines Agency. Accessed at European Medicines Agency at https:\/\/www.ema.europa.eu\/en\/committees\/pharmacovigilance-risk-assessment-committee-prac on February 11, 2024."},{"key":"10.1016\/j.vaccine.2024.02.065_b0475","unstructured":"Medicines & Healthcare products Regulatory Agency. Accessed at Medicines & Healthcare products Regulatory Agency at https:\/\/yellowcard.mhra.gov.uk\/ on February 11, 2024."},{"issue":"19","key":"10.1016\/j.vaccine.2024.02.065_b0480","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2022.03.030","article-title":"Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16\u201329 years","volume":"40","author":"Funk","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.065_b0485","unstructured":"Centers for Disease Control and Prevention 2021;Pages. Accessed at Centers for Disease Control and Prevention at https:\/\/www.cdc.gov\/media\/releases\/2021\/s0413-JJ-vaccine.html on September 29, 2023 2023."},{"key":"10.1016\/j.vaccine.2024.02.065_b0490","unstructured":"Food and Drug Administration 2021;Pages. Accessed at Food and Drug Administration at https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-june-25-2021 on July 2, 2023 2023."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T11:43:49Z","timestamp":1732535029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2400224X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":98,"alternative-id":["S0264410X2400224X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of U.S. COVID-19 vaccine safety surveillance systems","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125748"}}